β¨ Health Notices
920 NEW ZEALAND GAZETTE, No. 32 25 MARCH 2010
Health
Misuse of Drugs (Industrial Hemp) Regulations 2006
Approved Cultivar of Industrial Hemp
Acting pursuant to Regulation 5(1) of the Misuse of Drugs (Industrial Hemp) Regulations 2006, I, Sue Scott, Team Leader, Medicines Control, Regulation and Governance, Ministry of Health, acting under delegation from the Director-General of Health, hereby approve the cultivar of industrial hemp described below, for the purposes of that Regulation:
FEDORA 17
Dated at Wellington this 18th day of March 2010.
SUE SCOTT, Team Leader, Medicines Control, Regulation and Governance, Ministry of Health.
go2217
Medicines Act 1981
Consent to the Distribution of New Related Products
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related products set out in the Schedule hereto:
Schedule
Product: 3M ESPE Clinpro Tooth Creme
Active Ingredient: Sodium fluoride 0.21%w/w
Dosage Form: Toothpaste
New Zealand Sponsor: 3M New Zealand Limited
Manufacturer: Sheffield Laboratories, New London, United States of America
Product: Mouthfresh Fresh Mint Gel
Active Ingredient: Sodium monofluorophosphate 0.76%w/w
Dosage Form: Toothpaste
New Zealand Sponsor: Global Products Limited
Manufacturer: Bhavi Tubes and Containers Pvt Limited, Gujarat, India
Product: Mouthfresh Ice Mint Gel
Active Ingredient: Sodium monofluorophosphate 0.76%w/w
Dosage Form: Toothpaste
New Zealand Sponsor: Global Products Limited
Manufacturer: Bhavi Tubes and Containers Pvt Limited, Gujarat, India
Product: Oral-B Tooth and Gum Care Alcohol-Free Mouth Rinse
Active Ingredients:
- Cetylpyridinium chloride monohydrate 0.05%w/w
- Sodium fluoride 0.05%w/w
Dosage Form: Mouthwash
New Zealand Sponsor: Procter & Gamble Distributing New Zealand Limited
Manufacturer: Laboratorios Rety de Colombia S.A., Barranquilla, Colombia
Dated this 18th day of March 2010.
MARK RICHARDS, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go2166
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Hycamtin
Active Ingredient: Topotecan hydrochloride 0.27mg equivalent to 0.25mg topotecan
Dosage Form: Capsule
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Manufacturing SpA, Parma, Italy
Next Page →
β¨ LLM interpretation of page content
π₯ Approval of Industrial Hemp Cultivar
π₯ Health & Social Welfare18 March 2010
Industrial Hemp, Cultivar, Approval, FEDORA 17
- Sue Scott, Team Leader, Medicines Control, Regulation and Governance, Ministry of Health
π₯ Consent to Distribution of New Related Products
π₯ Health & Social Welfare18 March 2010
Medicines, Distribution, Toothpaste, Mouthwash
- Mark Richards, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health
π₯ Consent to Distribution of New Medicines
π₯ Health & Social Welfare18 March 2010
Medicines, Distribution, Hycamtin, Topotecan
- Mark Richards, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health
NZ Gazette 2010, No 32